Other Publication Details
Mandatory Fields
Reviews
Enright E.;Gahan C.;Joyce S.;Griffin B.
2016
September
The impact of the gut microbiota on drug metabolism and clinical outcome
Validated
1
Scopus: 48 ()
Optional Fields
Drug metabolism Gastrointestinal Microbiome Microbiota Pharmacokinetics
© 2016. The significance of the gut microbiota as a determinant of drug pharmacokinetics and accordingly therapeutic response is of increasing importance with the advent of modern medicines characterised by low solubility and/or permeability, or modified-release. These physicochemical properties and release kinetics prolong drug residence times within the gastrointestinal tract, wherein biotransformation by commensal microbes can occur. As the evidence base in support of this supplementary metabolic “organ” expands, novel opportunities to engineer the microbiota for clinical benefit have emerged. This review provides an overview of microbe-mediated alteration of drug pharmacokinetics, with particular emphasis on studies demonstrating proof of concept in vivo. Additionally, recent advances in modulating the microbiota to improve clinical response to therapeutics are explored.
0044-0086
375
382
Grant Details